Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Core Viewpoint - Abbott Laboratories is set to release its third-quarter earnings results on October 15, with expectations of increased earnings and revenue compared to the previous year [1]. Financial Performance - Analysts predict Abbott will report earnings of $1.30 per share, an increase from $1.21 per share in the same quarter last year [1]. - The company is projected to generate quarterly revenue of $11.4 billion, up from $10.63 billion a year earlier [1]. Dividend Information - On September 19, Abbott's board declared a quarterly common dividend of 59 cents per share [2]. Stock Performance - Abbott Laboratories shares experienced a decline of 0.6%, closing at $132.57 [2]. Analyst Ratings - Citigroup analyst Joanne Wuensch maintained a Buy rating but reduced the price target from $157 to $155 [4]. - Raymond James analyst Jayson Bedford kept an Outperform rating while lowering the price target from $142 to $141 [4]. - Mizuho analyst Anthony Petrone maintained a Neutral rating and cut the price target from $140 to $135 [4]. - Jefferies analyst Matthew Taylor upgraded the stock from Hold to Buy and raised the price target from $143 to $145 [4]. - BTIG analyst Marie Thibault maintained a Buy rating but reduced the price target from $148 to $145 [4].